Open original FDA record ↗Recall record
- FDA identifier
- Z-1179-2017
- Company in FDA record
- Ortho-Clinical Diagnostics
- FDA record creation date
- Feb 9, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is a potential for variable negatively and positively biased urine protein results using VITROS UPRO Slides.
Source facts
- Action
- On December 8, 2016, Ortho Clinical Diagnostics distributed Product Correction Notification letters to their customers via FedEx, ORTHO PLUS e-Communications and/ or US Postal Service Priority Mail. Customers are advised to check their stock for affected product and to immediately discontinue and discard all remaining inventory. Ortho will credit your account for any discarded VITROS UPRO Slides, VITROS Chemistry Products Calibrator Kit 10 and/or VITROS Chemistry Products UPRO Performance Verifier I & II. Please complete the Confirmation of Receipt and return by December 22, 2016. Customers with questions, please contact Ortho CareTM Technical Solutions Center at 1-800-421-3311.
- Initiated
- 2016-12-08
- Root cause
- Device Design
- Terminated
- 2018-06-22
- Distribution
- Worldwide distribution - Nationwide U.S.A; International - Bermuda, Australia, Canada, Chile, China, Colombia, India, Japan, Mexico, Republic of Panama, Singapore, Venezuela, England, France, Germany, Italy, Spain and Poland.
- Recall number
- Z-1179-2017
- Recall status
- Terminated
- CDRH record ID
- 151775
- FDA record created
- 2017-02-09
- Recall event number
- 75936